drugset / Trial / NCT05460858

NAC Effect on Infertile Women With Endometrioma

NCT05460858

Phase 3 Unknown 140 enrolled Royan Institute
RandomizedParallel-groupDouble-blindSupportive care

Summary

Oxidative stress has been investigated as a key factor in the pathogenesis and progression of endometrioma. High follicular fluid ROS levels and serum can be related to negative IVF/ICSI outcomes in infertile women with endometrioma. Therefore, the use of antioxidants such as N-acetyl cysteine (NAC) may be reduced complications of endometrioma. To study this hypothesis, we designed a double-blind, randomized clinical trial study that aimed to determine the effect of N-acetyl cysteine (NAC) on stress oxidative factors and pregnancy outcomes in IVF/ICSI cycles in endometrioma patients.

Timeline

Start
2021-04-13
Primary completion
2023-09-23
Completion
2023-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg